BUSINESS
Laurus Labs transfers ownership of HBV ANDA to CASI Pharmaceuticals
Laurus Labs has transferred the US Food and Drug Administration (USFDA) approved Abbreviated New Drug Application (ANDA) of Tenofovir Disoproxil Fumarate (TDF) to CASI Pharmaceuticals, Inc., a biopharmaceutical…